Mark Van Oene serves as the Chief Operating Officer at Pacific Biosciences of California, Inc. (PacBio), a leading provider of high-quality sequencing technologies. With an extensive background in life sciences and operational leadership, Van Oene has played a pivotal role in driving PacBio's growth and innovation. Before joining PacBio, he held significant positions at major biotechnology companies, including Illumina and Gen-Probe, where he honed his expertise in scaling operations and spearheading strategic initiatives. At PacBio, Van Oene oversees the company's global operations, focusing on enhancing production efficiency, quality control, and supply chain management. Under his leadership, PacBio has successfully expanded its manufacturing capabilities and improved the delivery of its cutting-edge sequencing platforms, such as the Sequel II and Revio systems. His strategic vision has been instrumental in positioning PacBio as a key player in the genomics market, enabling researchers worldwide to unlock new insights into genetics and biology. Van Oene's achievements extend beyond his operational roles. He has been recognized for his contributions to the biotechnology industry, receiving accolades for his leadership in driving technological advancements and fostering a culture of innovation. His commitment to excellence and customer satisfaction has solidified PacBio's reputation as a trusted partner in the scientific community, and his ongoing efforts continue to propel the company toward new heights of success.